Bovine TB found on Diddly Squat Farm, Jeremy Clarkson says
In a post on X, Clarkson wrote: 'Bad news from Diddly Squat. We've gone down with TB.
'Everyone here is absolutely devastated.'
Asked in the comments about the prize bull called Endgame, which Clarkson bought recently for £5,500 featured in the latest series, he said: 'His test was 'inconclusive'. I couldn't bear it if we lost him.'
He later wrote: 'The offending animal is pregnant with twins.'
Bad news from Diddly Squat. We've gone down with TB. Everyone here is absolutely devastated.
— Jeremy Clarkson (@JeremyClarkson) July 31, 2025
Clarkson also clarified the disease is Bovine TB, which does not affect people but 'just our poor cows'.
Cattle which fail a TB test, or animals that have inconclusive results for two consecutive tests, and are classed as 'reactors', must be isolated then to slaughter.
Bovine TB is recognised as a problem which devastates farm businesses, spreading from badgers to cattle, and from cow to cow.
Badger culling has long been a part of the Government response to the disease, despite criticism from wildlife and animal welfare campaigners.
The Government last month said it will not be extending the badger cull and retains its commitment to end the practice before the next election.
Oxfordshire is an 'edge area' for TB, meaning it is a buffer zone between high risk and low risk areas – so most herds are subject to six monthly TB tests by default.
There have been several cases in the area of Oxfordshire near to Diddly Squat Farm in recent weeks, according to ibTB, a mapping platform for the disease in England and Wales.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
10 hours ago
- Telegraph
Antimicrobial resistance and the fight to prevent a real-life The Last of Us
In the popular zombie-apocalypse TV show The Last of Us, humans become infected with parasitic fungi, causing a blooming fungal amour to sprout from their skulls. It's gripping TV but in the real-world, deaths from fungal infections have doubled in the last decade and drug-resistant fungi are showing an alarming upward trajectory, making this fictional threat feel uncomfortably close to reality. Antimicrobial resistance (AMR), when fungi, bacteria, viruses and parasites evolve to resist the antimicrobial medicines designed to kill them, is quickly accelerating, fuelling a 'silent pandemic'. Since 1990, at least one million people have died from AMR every year. In the next 25 years, it could cause the deaths of almost 40 million people. Low- and middle-income countries like my own, Nigeria, face a dual challenge. First, a lack of access to antimicrobials leads to more deaths from AMR and actually makes the resistance problem worse. And overuse of antimicrobials in other parts of the world – particularly in healthcare and agriculture – is also fuelling resistance. The result is not just a health crisis but a development emergency. A recent study found that AMR economically hits low- and middle-income countries the hardest. Today, it costs approximately $66 billion and this is set to rise to $159 billion if action is not taken to effectively curb it. In the midst of this worsening crisis, the UK Government recently announced that it is shutting the Fleming Fund – named after the discoverer of penicillin and a key player in the fight against AMR. While bad for UK science and the broader global effort to tackle AMR, it now falls on others to take up the baton to tackle one of the world's most existential threats. The good news is that new leadership is emerging in the countries hit the hardest. This month, the Government of Nigeria announced it will host the fifth Global High-Level Ministerial Conference on AMR in 2026 – the first time the event will be held in Africa. While promising developments, such as the antibiotic zosurabalpin, currently undergoing human trials, or the use of artificial intelligence in drug discovery, give reason for cautious optimism, there is much more to be done to ensure that life-saving treatments are available to the people that need them. First, we must prioritise access to quality diagnostic tools, our first line of defence against AMR. Diagnostics ensure that antimicrobials are used appropriately, increasing patients' chances of recovery while slowing resistance. They also protect new discoveries by preventing unnecessary use. Diagnostics are not just critical for individual patients, they are vital for tracking resistance patterns across animal, and environmental health; sectors which are deeply interlinked in our fight against AMR. Today most of the world is fighting AMR without access to diagnostics. Without them, we're not just under-equipped – we're fighting blind. Second, we must expand access to antimicrobials, create the market conditions needed for further drug development, and ensure that every country implements and enforces a national action plan for AMR. Research in the Lancet across eight low- and middle-income countries found less than seven percent of people with drug-resistant bacterial infections could access the antibiotics they needed. Without these medicines, both patients and the wider community are at risk, as pathogens spread and evolve. Third, we must dramatically increase investment in innovation and strengthen the fragile antimicrobial pipeline. New antimicrobials are urgently needed to meet growing global demand and unmet needs. At the fourth Global High-Level Ministerial Conference on AMR in Jeddah, Saudi Arabia, leaders acknowledged the weak pipeline for new antibiotics and the market failures holding back development. The economic model is broken. Antibiotic research is costly, slow, and high-risk: for new classes of antibiotics, only one in 30 candidates will reach patients, and these are often reserved as a last resort. Government and industry must act urgently and ambitiously to reform the market to mobilise innovation. We need new economic models that reward long-term public health benefits, not just short-term profits. Finally, diagnostic and antimicrobial access and innovations must be backed by strong national action plans. At the second high level meeting on AMR at the 79th United Nations General Assembly, global leaders committed to developing or implementing national AMR action plans. At that time, while 178 countries had developed multi-sectoral national action plans, only 68 percent were implementing these plans. Last year, Nigeria launched its second national action plan on AMR, building on efforts to curb overuse and misuse of antimicrobials across human and animal health. But as we have learnt from Covid-19, pathogens do not know borders. Containing AMR demands global, coordinated action and accountability. We're not in the apocalyptic world of The Last of Us just yet but AMR has long been claiming lives, and is a blight on our health systems and economies. The decisive action we take in the next year will be key to preventing the unravelling of modern medicine.
Glasgow Times
16 hours ago
- Glasgow Times
'As shadow minister for women's health, I see scandalous injustices'
But it is my current role as shadow minister for women's health where I see some of the most scandalous injustices. The various facets of gender inequality are well documented, and hardly exclusive to Scotland. Across the developed world, we are paid less than our male counterparts, less likely to be promoted and the caring responsibilities at home almost always fall on us. More seriously, women are predominantly the victims of domestic violence, a scourge that gets worse every year. And of course, elsewhere in the world, the picture for female welfare is worse still, even when it comes to the most basic of human rights. One area that tends to slip under the radar in Scotland is women's health, especially those conditions that are exclusive to us. Last week, statistics were finally published in relation to cervical cancer, a serious killer among women. The data gathering for this has been a farce over the past few years, and some of the statistics published by Public Health Scotland pose more questions than they answer. Within the document, it stated that of those invited for screening last year, barely 50% showed up for the process. When my office's own research produced a similar figure earlier this year, a Scottish Government minister got in touch to say my conclusion was wrong. And yet PHS, the SNP government's own agency, appears to have arrived at the same result. For women in deprived areas, the screening rate is even poorer. That means, right across the country, there are thousands of women at risk of serious illness and death because the government cannot properly get through to them and convince them of the need to get checked. Another poorly served cohort is women suffering from endometriosis, a painful and debilitating disease that can have a major impact on those trying to have a baby. The situation is different from cervical screening, as anyone requiring treatment will know about it due to the hellish impact it has on their life. Addressing those issues should be a priority for the NHS, yet the statistics indicate it is anything but. My research shows that across Scotland, there are hundreds of women waiting in agony to commence treatment. In some health boards, the longest waits for this to happen run into hundreds of days. For a woman living with this, the experience is unbearable. It's not just the pain and anxiety – often their entire life is on hold. That can range from family planning and long-held personal ambitions to career progression or further study. Again, these issues aren't exclusive to Scotland. But they are exclusive to women, and if we are to be serious about reducing all gender inequalities, the care of conditions which only women experience needs to be better. We keep hearing about the challenges the NHS faces in Scotland, but the fact it is entirely devolved to the Scottish Parliament can also be considered an opportunity. By improving the treatment of and screening for conditions which only affect women, we could be a genuine world leader and example in this field. Better still, achieving it would also greatly improve the quality of life for a great many females in this country.
Belfast Telegraph
a day ago
- Belfast Telegraph
NI health department in discussions about accepting a number of seriously injured children from Gaza
It's understood that any decision will be subject to Executive approval. Plans to evacuate more seriously ill or injured children from Gaza and bring them to the UK for medical treatment are being carried out "at pace", the Government has said. It is unclear how many children might be involved, but it has been reported that the Government is to allow up to 300 young people to enter the UK to receive free medical care. Ministers will enable children in severe need to receive taxpayer-funded care. Some Gazan children have already been brought privately to the UK for medical treatment through an initiative by Project Pure Hope, but the Government has so far not evacuated any through its own scheme during the conflict. More than 60,000 Palestinians have been killed in Gaza, according to its health ministry, but The Lancet medical journal has previously estimated that deaths due to traumatic injuries is likely to be 40% higher. Starvation in Gaza is 'unnacceptable', says Peter Kyle ahead of emergency Cabinet meeting The number of injuries reached a new milestone of more than 150,000 injured or wounded in the past 22 months – one in 14 across the small strip of land. Citing figures from the Gaza Health Ministry, Al Jazeera has said that 18,500 will require long-term rehabilitation, 4,700 have had one or more limbs amputated as a result of their injuries and nearly 1,000 of them are children. More than 45,000 children are reported to have lost one or both parents. Sinn Féin MLA Philip McGuigan has written to the Health Minister urging support for an initiative to provide treatment for seriously ill or injured children from Gaza. The party's health spokesperson was speaking after media reports said the UK Government is to launch a scheme to evacuate children injured in Israel's ongoing genocidal campaign. 'The level of human suffering in Gaza, particularly among children, is appalling and intolerable,' said Mr McGuigan. 'I've written to Minister Nesbitt to ask what involvement his department has had in this initiative, and urged him to do everything possible to support these young people who are in such desperate need of assistance. 'Israel's systematic targeting of hospitals and other critical services, and its continued blockade, is causing devastation to an already beleaguered population. 'The Health Minister must now back this scheme and ensure every effort is made to provide healthcare to the sick and injured children of Gaza.' The Department of Health said it is engaging with the UK Government and the other devolved administrations 'on the possibility of providing medical treatment in the UK for children from Gaza.' It added: 'Discussions are ongoing regarding the possibility of accepting a small number of children.'
